IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Jun 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-05-28

Reporting Person: POLEWACZYK JAMES F (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-28	Common Stock	M	10000	$67.85	Acquired	29915	Direct
2021-05-28	Common Stock	S	1039	$558.8934	Disposed	28876	Direct
2021-05-28	Common Stock	S	1370	$559.7656	Disposed	27506	Direct
2021-05-28	Common Stock	S	1274	$560.7933	Disposed	26232	Direct
2021-05-28	Common Stock	S	1429	$561.7710	Disposed	24803	Direct
2021-05-28	Common Stock	S	2462	$562.6535	Disposed	22341	Direct
2021-05-28	Common Stock	S	1713	$564.0384	Disposed	20628	Direct
2021-05-28	Common Stock	S	513	$564.7257	Disposed	20115	Direct
2021-05-28	Common Stock	S	200	$565.555	Disposed	19915	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-28	Non-Qualified Stock Option (right-to-buy)	$67.85	M	10000	Disposed	2026-02-13	Common Stock (10000)	Direct

Footnotes

F1: Includes 12 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021.

F2: Represents the weighted average price of the shares sold ranging from a low of $558.22 to a high of $559.22 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F3: Represents the weighted average price of the shares sold ranging from a low of $559.23 to a high of $560.22 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F4: Represents the weighted average price of the shares sold ranging from a low of $560.24 to a high of $561.24 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F5: Represents the weighted average price of the shares sold ranging from a low of $561.25 to a high of $562.24 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F6: Represents the weighted average price of the shares sold ranging from a low of $562.26 to a high of $563.155 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F7: Represents the weighted average price of the shares sold ranging from a low of $563.36 to a high of $564.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F8: Represents the weighted average price of the shares sold ranging from a low of $564.38 to a high of $564.88 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F9: Represents the weighted average price of the shares sold ranging from a low of $565.42 to a high of $565.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F10: Grant of option to buy 12,627 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2017.

F11: Not applicable.